CJC-1295 DAC 2 mg: What This Research Peptide Vial Contains

CJC-1295 DAC 2 mg refers to a 2 milligram vial of CJC-1295 with Drug Affinity Complex, a long-acting growth hormone-releasing hormone (GHRH) analog sold for laboratory research. The "2 mg" label describes the amount of lyophilized peptide powder in the vial, not a suggested human dose. CJC-1295 DAC is not FDA-approved for human use in the United States.

What Is CJC-1295 DAC 2 mg?

CJC-1295 is a synthetic peptide designed to mimic GHRH, the hormone that tells the pituitary gland to release growth hormone. The "DAC" stands for Drug Affinity Complex, a modification that lets the peptide bind to albumin in the bloodstream. That binding slows clearance and gives CJC-1295 with DAC a much longer half-life than the version without it.

A 2 mg vial is the smallest standard research format. Labs use it for small pilot studies or for compounds that are reconstituted and used quickly.

• Peptide content: 2 mg of lyophilized CJC-1295 DAC powder
• Purity: Typically 95–99% in research-grade supplies
• Form: White lyophilized powder in a sealed vial
• Storage: Refrigerated or frozen, protected from light

How CJC-1295 With DAC Works

CJC-1295 DAC binds to GHRH receptors in the pituitary, triggering growth hormone release. The DAC portion attaches to endogenous albumin, which protects the peptide from rapid enzymatic breakdown. As a result, a single administration in research models can elevate growth hormone levels for several days.

This is different from shorter-acting GHRH analogs, which peak and clear within hours. The extended activity is the main reason researchers choose CJC-1295 DAC over other GHRH options.

None of this means the peptide treats any disease. CJC-1295 DAC remains an investigational compound, and its effects in humans are not fully characterized.

CJC-1295 DAC 2 mg vs 5 mg vs 10 mg Vials

Vial size only changes the amount of powder; the peptide itself is identical. Larger vials are more economical per milligram but require more careful reconstitution and storage.

Vial Size	Powder Amount	Common Research Reconstitution	Typical Use Case
2 mg	2 mg	1–2 mL bacteriostatic water	Small pilot assays, short studies
5 mg	5 mg	2–3 mL bacteriostatic water	Mid-size experiments
10 mg	10 mg	3–5 mL bacteriostatic water	Long-term or multi-arm studies

Many suppliers list 5 mg and 10 mg vials as separate products. The 2 mg vial is often chosen when a lab wants to minimize waste or test a new batch.

CJC-1295 DAC vs No DAC

The cjc-1295 dac vs no dac comparison comes down to half-life and albumin binding. CJC-1295 without DAC is sometimes called Mod GRF (1-29) and clears much faster.

Feature	CJC-1295 With DAC	CJC-1295 Without DAC
Albumin binding	Yes	No
Half-life in research models	Several days	Approximately 30 minutes
Frequency studied	Once weekly or less	One to three times daily
Common research stack	Alone or with a GHRP	Often paired with ipamorelin

Because the shorter version clears quickly, its dosing schedule is tighter. Researchers looking at cjc-1295 no dac dosage typically study more frequent administration than they would with the DAC version.

Dosing and Reconstitution in Research Settings

There is no FDA-approved human dose of CJC-1295 DAC. Published research often uses microgram-per-kilogram amounts in animal models, not fixed human recommendations. The question "how much cjc 1295 with dac should i take" cannot be answered with a safe, universal number.

When researchers discuss cjc-1295 with dac dosage, they usually refer to study protocols, not consumer guidance. Any human use is off-label, unregulated, and carries unknown risks.

Reconstitution is a separate step. A 2 mg vial is typically mixed with 1–2 mL of bacteriostatic water, yielding a clear solution. The vial should be swirled, not shaken, and stored refrigerated.

Why 2 mg Vials Are Popular for Reconstitution

Smaller vials mean less peptide sitting in solution after reconstitution. Peptides degrade over time, so a 2 mg vial can reduce waste in short experiments. That said, larger vials may be more cost-effective for long protocols.

Safety, Legality, and Sourcing

CJC-1295 DAC is not approved by the FDA for human use. In the US, it is sold as a research chemical, not a dietary supplement or prescription drug. Buyers looking for cjc 1295 dac for sale should understand that product quality varies widely between vendors.

Potential side effects reported in anecdotal human use include injection site reactions, headache, and changes in blood sugar or hormone levels. No long-term safety data exists for CJC-1295 DAC in humans.

Consult a healthcare professional before considering any peptide. Self-administering unapproved research chemicals can cause harm, and legal status may change.

Key Points About CJC-1295 DAC 2 mg

• CJC-1295 DAC 2 mg is a 2 milligram research vial of a long-acting GHRH analog.
• The 2 mg label describes powder quantity, not a human dose.
• DAC extends half-life by binding to albumin, unlike CJC-1295 without DAC.
• CJC-1295 DAC is not FDA-approved and is sold for research only.
• No established human dosing protocol exists, and safety data is limited.

COMMON QUESTIONS

Frequently Asked Questions

What is CJC-1295 DAC 2 mg used for?

CJC-1295 DAC 2 mg is sold as a research chemical for laboratory studies on growth hormone release. It is not approved for human use, and no medical treatment is associated with this peptide. Researchers use it to study GHRH receptor activity and extended half-life effects in animal models.

How much CJC-1295 with DAC should I take?

There is no safe or FDA-approved human dose of CJC-1295 DAC. Dosing information from research is based on animal models and cannot be directly translated to humans. Anyone considering this peptide should consult a licensed healthcare professional.

Is CJC-1295 DAC legal in the US?

CJC-1295 DAC is not FDA-approved for human use, but it is legally sold as a research chemical for laboratory purposes. It is not a dietary supplement, and importing it for personal use may violate FDA rules. Legality can change, so check current regulations.